Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Brain Pathology (Zurich, Switzerland)
|
February 4, 2025
Peripheral blood-derived immune cell counts as prognostic indicators and their relationship with DNA methylation subclasses in glioblastoma patients
Benedikt Asey, Tobias F Pantel, Malte Mohme, et al.
Cancer Discovery
|
December 2, 2025
Reflections on Advances in Cancer Research in 2025
Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Elife
|
June 25, 2021
Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity
Ophir Shani, Yael Raz, Lea Monteran, et al.
Nature Genetics
|
October 1, 2021
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Ronan Chaligne, Federico Gaiti, Dana Silverbush, et al.
Neuro-Oncology
|
July 29, 2025
Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic Signatures
Yuji Matsumoto, Omkar Singh, Jose Garcia, et al.
Nature
|
September 20, 2019
Electrical and synaptic integration of glioma into neural circuits
Humsa S Venkatesh, Wade Morishita, Anna C Geraghty, et al.
Acta Neuropathologica
|
January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Richard Drexler, Robin Khatri, Ulrich Schüller, et al.
Cell Systems
|
August 24, 2018
Principles of Systems Biology, No. 31
Hyunghoon Cho, Bonnie Berger, Jian Peng, et al.
Nature Medicine
|
June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Brain Pathology (Zurich, Switzerland)
|
February 4, 2025
Peripheral blood-derived immune cell counts as prognostic indicators and their relationship with DNA methylation subclasses in glioblastoma patients
Benedikt Asey, Tobias F Pantel, Malte Mohme, et al.
Cancer Discovery
|
December 2, 2025
Reflections on Advances in Cancer Research in 2025
Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti, et al.
Elife
|
June 25, 2021
Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity
Ophir Shani, Yael Raz, Lea Monteran, et al.
Nature Genetics
|
October 1, 2021
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Ronan Chaligne, Federico Gaiti, Dana Silverbush, et al.
Neuro-Oncology
|
July 29, 2025
Intra-tumoral Preservation of the Stem-like Malignant Cell Proportion in Glioblastoma, Prognostic Impact, and its Radiomethylomic Signatures
Yuji Matsumoto, Omkar Singh, Jose Garcia, et al.
Nature
|
September 20, 2019
Electrical and synaptic integration of glioma into neural circuits
Humsa S Venkatesh, Wade Morishita, Anna C Geraghty, et al.
Acta Neuropathologica
|
January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Richard Drexler, Robin Khatri, Ulrich Schüller, et al.
Cell Systems
|
August 24, 2018
Principles of Systems Biology, No. 31
Hyunghoon Cho, Bonnie Berger, Jian Peng, et al.
Nature Medicine
|
June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Page
of 3